Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes

Journal of Immunoassay and Immunochemistry

Volumn 28, Issue 3, 2007, Pages 267-277

  Redwan, El Rashdy M ^a   Tabll, Ashraf ^b  

^a Universities and Research centers District   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Camel milk; Hepatitis C virus; Inhibition; Lactoferrin; Purification

Indexed keywords

LACTOFERRIN;

ANTIVIRAL ACTIVITY; ARTICLE; BIOCHEMISTRY; CAMEL; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CROSS REACTION; EGYPT; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INCUBATION TIME; LEUKOCYTE; MILK; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRADITIONAL MEDICINE; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; CAMELS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; LACTOFERRIN; LEUKOCYTES, MONONUCLEAR;

EID: 34347394504     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321810701454839     Document Type: Article

References (25)

1. Brass, V.; Moradpour, D.; Blum, H.E. Molecular virology of hepatitis C virus (HCV): 2006 update. Int. J. Med. Sci. 2006, 3, 29-34.
2. Genovese, D.; Dettori, S.; Argentini, C.; Villano, U.; Chionne, P.; Angelico, M.; Rapicetta, M. Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. J. Clin. Microbiol. 2005, 43, 1902-1909.
3. Khan, J.A.; Kumar, P.; Paramasivam, M.; Yadav, R.S.; Sahani, M.S.; Sharma, S.; Srinivasan, A.; Singh, T.P. Camel lactoferrin, a transferrin-cum-lactoferrin: crystal structure of camel apolactoferrin at 2.6 A resolution and structural basis of its dual role. J. Mol. Biol. 2001, 309, 751-761.
4. Farnaud, S.; Evans, R.W. Lactoferrin-a multifunctional protein with antimicrobial properties. Mol. Immunol. 2003, 40, 395-405.
5. Yi, M.; Kaneko, S.; Yu, D.Y.; Murakami, S. Hepatitis C virus envelope proteins bind lactoferrin. J. Virol. 1997, 71, 5997-6002.
6. Ikeda, M.; Sugiyama, K.; Tanaka, T.; Tanaka, K.; Sekihara, H.; Shimotohno, K.; Kato, N. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem. Biophys. Res. Commun. 1998, 245, 549-553.
7. Ikeda, M.; Nozaki, A.; Sugiyama, K.; Tanaka, T.; Naganuma, A.; Tanaka, K.; Sekihara, H.; Shimotohno, K.; Saito, M.; Kato, N. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus. Res. 2000, 66, 51-63.
8. Iwasa, M.; Kaito, M.; Ikoma, J.; Takeo, M.; Imoto, I.; Adachi, Y.; Yamauchi, K.; Koizumi, R.; Teraguchi, S. Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b. Am. J. Gastroenterol. 2002, 97, 766-767.
9. Ishii, K.; Takamura, N.; Shinohara, M.; Wakui, N.; Shin, H.; Sumino, Y.; Ohmoto, Y.; Teraguchi, S.; Yamauchi, K. Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hepatol. Res. 2003, 25, 226-233.
10. Hirashima, N.; Orito, E.; Ohba, K.; Kondo, H.; Sakamoto, T.; Matsunaga, S.; Kato, A.; Nukaya, H.; Sakakibara, K.; Ohno, T.; Kato, H.; Sugauchi, F.; Kato, T.; Tanaka, Y.; Ueda, R.; Mizokami M.A. Randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral load. Hepatol. Res. 2004, 29, 9-12.
11. Konishi, M.; Iwasa, M.; Yamauchi, K.; Sugimoto, R.; Fujita, N.; Kobayashi, Y.; Watanabe, S.; Teraguchi, S.; Adachi, Y.; Kaito, M. Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C. Hepatol. Res. 2006, Jul 18; [Epub ahead of print].
12. Redwan, E.M.; Larsen, N.L.; Wilson, I.A. Simplified procedure for elimination of co-purified contaminant proteins from human colostrums IgA1. J. Egypt. Ger. Soc. Zool. 2003, 40A, 251-260.
13. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
14. EL-Awady, M.K.; Tabll, A.A.; Redwan, E.M.; Youssef, S.; Omran, M.H.; El-Demellawy, M. Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: Binding and entry. World J. Gastroenterol. 2005, 11, 5203-5208.
15. Mizutani, T.; Kato, N.; Ikeda, M.; Sugiyama, K.; Shimotohno, K. Long-term human T-cell culture system supporting hepatitis C virus replication. Biochem. Biophys. Res. Comm. 1996, 227, 822-826.
16. Nozaki, A.; Ikeda, M.; Naganuma, A.; Nakamura, T.; Inudoh, M.; Tanaka, K.; Kato, N. Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein. J. Biol. Chem. 2003, 278, 10162-10173.
17. Bartosch, B.; Cosset, F.L. Cell entry of hepatitis C virus. Virology 2006, 25, 1-12.
18. Tscherne, D.M.; Jones, C.T.; Evans, M.J.; Lindenbach, B.D.; McKeating, J.A.; Rice, C.M. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J. Virol. 2006, 80, 1734-1741.
19. Legrand, D.; Elass, E.; Pierce, A.; Mazurier, J. Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties. Biometals 2004, 17, 225-229.
20. Farinati, F.; Cardin, R.; De Maria, N.; Della Libera, G.; Marafin, C.; Lecis, E.; Burra, P.; Floreani, A.; Cecchetto, A.; Naccarato, R. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J. Hepatol. 1995, 22, 449-456.
21. Bonkovsky, H.L.; Banner, B.F.; Rothman, A.L. Iron and chronic viral hepatitis. Hepatology 1997, 225, 759-768.
22. Kappeler, S.R.; Heuberger, C.; Farah, Z.; Puhan, Z. Sequence analysis of camel (Camelus dromedaries) lactoferrin. J. Dairy Sci. 2004, 87, 2660-2668.
23. Chenna, R.; Sugawara, H.; Koike, T.; Lopez, R.; Gibson, T.J.; Higgins, D.G.; Thompson, J.D. Multiple sequence alignment with the clustal series of programs. Nucleic Acids Res. 2003, 31, 3497-3500.
24. Petracca, R.; Falugi, F.; Galli, G.; Norais, N.; Rosa, D.; Campagnoli, S.; Burgio, V.; Di Stasio, E.; Giardina, B.; Houghton, M.; Abrignani, S.; Grandi, G. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J. Virol. 2004, 74, 4824-4830.
25. Flint, M.; Thomas, J.M.; Maidens, C.M.; Shotton, C.; Levy, S.; Barclay, W.S.; McKeating, J.A. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J. Virol. 1999, 73, 6782-6790.